Disc Medicine Stock (NASDAQ:IRON)
Previous Close
$47.15
52W Range
$25.64 - $68.73
50D Avg
$54.08
200D Avg
$52.90
Market Cap
$1.68B
Avg Vol (3M)
$402.39K
Beta
2.85
Div Yield
-
IRON Company Profile
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
IRON Performance
Peer Comparison
| Ticker | Company |
|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. |
| OBIO | Orchestra BioMed Holdings, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| GPCR | Structure Therapeutics Inc. |
| MORF | Morphic Holding, Inc. |
| ADAG | Adagene Inc. |
| ANAB | AnaptysBio, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| CNTA | Centessa Pharmaceuticals plc |
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools